Gene Query: DCLRE1A

Dataset Description Geneva Score
Effect of 48h treatment with 100nM GSK2879552 on T-ALL cell lines LOUCY and PEER 49.67
LNCaP treated with iBET 26.47
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 19.75
Transcriptomic analysis to functionally map the intrinsically disordered domain of EWS/FLI [Experiment 1] 19.41
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection 19.28
Suppression of ribosomal pausing by eIF5A is necessary to maintain the fidelity of start codon selection (RNA-sequencing) 19.28
Analysis of transcriptome changes following SOX2 knockdown in three different Ewing sarcoma cell lines 17.66
Genomic expression analysis of K562 cells expressing shRNA targeting lncRNA-IIRX and control cells 16.11
BCL6 confers KRAS-mutant NSCLCs resistance to BET inhibitors 14.79
Impact of ETV7 activity on interferon-stimulated gene expression in 293T cells treated with interferon alpha 13.07
ETV7 and interferon response 13.07
Genome-wide chromatin analysis of Ewing sarcoma 12.07
Genome-wide chromatin analysis of Ewing sarcoma (RNA-seq) 12.07
Splicing towards noncoding isoforms in colorectal carcinoma is associated with tumor hypoxia and the DNA damage response 11.97
Small molecule targets TMED9, promotes lysosomal degradation to reverse proteinopathy 11.93
RNA-seq Analysis of Castration-Resistant Prostate Cancer With Knock-down of E2F1 11.73
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation I 11.13
Epigenome-wide Effects of Vitamin-D on Bronchial Epithelial Cells using ATAC-Seq and RNA-seq 10.63
Anaylsis of the effect of down-regulation of the EWS-FLI1 fusion protein in Ewing Sarcoma cells by RNA-seq. 10.48
24hr CA treatment vs. DMSO in HCT116 cells (from 'Identification of CDK8 and CDK19 substrates in human cells using cortistatin A and quantitative phosphoproteomics') 10.25
RNA-seq of three Ewing sarcoma cell lines (A673, SK-N-MC, RDES), transfected with either siControl or siMYBL2. 10.1
Cooperation of dominant oncogenes with regulatory variants shapes clinical outcomes in pediatric cancer 10.1
Expression profiles of restoration of BAP1 in a BAP1 deficient cell line 9.95
Transcriptome analysis of BAP1 knockout and restoration 9.95
Post-transcriptional manipulation of TERC reverses molecular hallmarks of telomere disease 9.89
Total RNA-seq in ALL-SIL upon JQ1 inhibition 9.86
Epigenome Editing by a CRISPR/Cas9-Based Acetyltransferase Activates Genes from Promoters and Enhancers 9.43
Human cell line and subcutaneous tumor 9.03
Gene expression in PANC1 cells treated with Rakicidin 9.0
Quantitative Analysis of PPARD Transcriptomes in Colon Cancer Cells by Next Generation Sequencing (NGS) 8.73
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 8.53
Triplet nucleotide repeat-based siRNAs are highly toxic to cancer cells 8.33
Genome-wide analysis of the Integrator complex 8.03
Genome-wide analysis of the Integrator complex (HTS) 8.03
Histone Demethylase-Assisted Somatic Cell Nuclear Transfer Facilitates Derivation of Human Pluripotent Stem Cells 7.78
A damaged genome's transcriptional landscape through multilayered expression profiling around in situ-mapped DNA double-strand breaks 7.68
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 7.51
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [whole transcriptome RNA-seq] 7.41
Tracking of dCas9-methyltransferase footprints 7.36
ICE1 promotes the link between splicing and nonsense-mediated mRNA decay 7.28
Aging Human Hematopoietic Stem Cells Manifest Profound Epigenetic Reprogramming of Enhancers That May Predispose to Leukemia (RNA-seq of KLF6 KO) 7.21
Tracing Enhancer Networks using Epigenetic Traits (TENET) 7.17
Hijacking of stress response machinery by oncogenes in acute leukaemia 7.02
Hijacking of stress response machinery by oncogenes in acute leukaemia [RNA-seq] 7.02
Genistein and bisphenol A exposure cause estrogen receptor 1 to bind thousands of binding sites in a cell type-specific manner 7.0
EWS-Fli and LNC regulated genes in comparison to GFP samples 6.98
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition 6.94
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and are Targetable by BET Bromodomain Inhibition [RNA-seq] 6.94
CD95L derived si- and shRNAs and the CD95L mRNA kill cancer cells through an RNAi mechanism by targeting survival genes [siL3.RNAseq.lg] 6.89
Expression data from A2780 cells treated with DMSO, Olaparib(Ola), Palbociclib(PD), and their combination (Ola/PD) 6.66
Conserved roles for murine mDUX and human DUX4 in activating cleavage stage genes and MERVL/HERVL retrotransposons [RNA-Seq] 6.57
A Unique Epigenomic Landscape Defines Human Erythropoiesis 6.5
A Unique Epigenomic Landscape Defines Human Erythropoiesis (RNA-seq) 6.5
hnRNP L protects mRNAs from nonsense-mediated mRNA decay 6.48
N6-methyladenine DNA Modification in Glioblastoma [RNA-seq] 6.46
N6-methyladenine DNA Modification in Glioblastoma 6.46
Cohesin and CTCF Differentially Affect the Chromatin Architecture and Gene Expression in Human Cells 6.44
Identification of Nrf2 regulated genes by RNA sequencing 6.42
Nrf2 regulated genes in A549 cells 6.42
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 6.41
A549 cells and MSR-A549 cells 6.4
mRNA expression profile of A549 cells and MSR-A549 cells with or without JQ1 treatment 6.4
Isolation and Transcriptome Analyses of Human Erythroid Progenitors: BFU-E and CFU-E 6.26
Therapeutic targeting of KDM1A/LSD1 in Ewing sarcoma engages the ER-stress response II 6.24
Comparison between THP-1 cells obtained from either ATCC or DSMZ biorepository 6.23
Response of HEK293 Freestyle cells to 36 h of culture in Zn(II)-depleted Freestyle medium 6.04
LncRNA-GAS5 negative regulation of YAP-target genes expression 5.96
Transcriptome analysis of total RNA in human osteosarcoma cell line U2OS before and after inhibition of zinc finger protein ZNF768 5.87
Transcriptional profiling of LS1034 cells treated with tepoxalin 5.74
Identification of global regulators of T-helper cell lineage specification 5.73
Identification of global regulators of T-helper cell lineage specification (RNA-Seq) 5.73
Strand-specific Dual RNA-seq of Bronchial Epithelial cells Infected with Influenza A/H3N2 Viruses Reveals Splicing of Gene Segment 6 and Novel Host-Virus Interactions 5.7
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma (RNA-Seq) 5.69
Bromodomain inhibition of the transcriptional coactivators CBP/EP300 as a therapeutic strategy to target the IRF4 network in multiple myeloma 5.69
MYCL and EP400 are required for Max and MCPyV mediated gene activation 5.67
Regulation of protein translation during mitosis 5.61
Interactions of aCPs with Cytosine-rich Polypyrimidine Tracts Enhance Splicing of Cassette Exons 5.53
RNA-seq of YB5 cells treated with Proscillaridin A 5.5
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 5.47
Spatially Constrained Tandem Bromodomain Inhibition Bolsters Sustained Repression of BRD4 Transcriptional Activity for TNBC Cell Growth 5.46
Effect of CHKA knockdown on C4-2 cell transcriptome 5.41
Biological effect of chronic mistranslation in mammalian cells 5.29
Transcriptomics analysis of gene expression in normal and METTL3 or WTAP deficient Human HeLa cells 5.28
The E3 ubiquitin ligase HectD1 suppresses EMT and metastasis by targeting the +TIP protein ACF7 for degradation 5.25
Cancer avatars derived from genetically engineered pluripotent stem cells allow for longitudinal assessment of tumor development 5.19
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 5.19
RNA-seq analysis to identify the genes regulated by p53-SET interplay 5.15
ELF4 is a target of miR-124 and promotes neuroblastoma proliferation and undifferentiated state 5.1
lncRNA-PCAT1 knockdown effect on the gene expression of androgen independent LNCaP (LNCaP-AI) cell line 5.08
TRIM28 interacts with EZH2 and SWI/SNF to activate genes that promote mammosphere formation 5.05
Transcriptome-wide identification of splicing defects upon XAB2 knockdown 5.0
Supraphysiological Androgens Repress Prostate Cancer Growth and Induce DNA Damage Augmented by PARP Inhibition 4.98
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 4.97
Hit-and-run' programing of CAR-T cells using mRNA nanocarriers 4.95
RNA-seq of synchronized S phase or G2 phase cells treated with an ATR inhibitor 4.9
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 4.9
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 4.9
IRF1 regulates IFN dependent and independent gene expression 4.88
Activation of Wnt/beta-catenin in Ewing sarcoma cells antagonizes EWS/ETS function and promotes phenotypic transition to more metastatic cell states 4.84
Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis 4.83
Altering cancer transcriptomes using epigenomic inhibitors 4.8
Altering cancer transcriptomes using epigenomic inhibitors [RNA-Seq] 4.8
RNA-seq analysis of differentiating human erythroblasts 4.8
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.79
Activation of the p53 transcriptional program sensitizes cancer cells to Cdk7 inhibitors 4.79
m6A-seq data analysis of control and PCIF1 knockdown transcriptome 4.78
An Alternative Splicing Event Amplifies Evolutionary Differences Between Vertebrates 4.77
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition [RNA-Seq] 4.73
Intragenic DNA methylation modulates alternative splicing by recruiting MeCP2 to promote exon recognition 4.73
Global Transcriptome Analyses of Mammalian Terminal Erythroid Differentiation 4.72
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.62
Short and Long RNA sequencing of human mature erythrocytes 4.62
Quantitative mass spectrometry-based proteomics reveals the dynamic protein landscape during initiation of human Th17 cell polarization 4.51
PRDM1 inhibits proliferation of human colon cancer organoids 4.41
The stress granule transcriptome reveals principles of mRNA accumulation in stress granules. 4.39
RNA-Seq analysis of JIB-04 effects on global cellular transcription and HIV in 2D10 T cells 4.36
Impact of dieldrin on transcription in Jurkat T cells 4.34
Effect of ER stress on MUC1 kidney disease patient derived cells and and treatment by BRD4780 4.32
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs [RNA-seq] 4.29
ELF1 expression in prostate cells reduces oncogenic ETS functions and promotes senescence and sensitivity to chemotherapy through distinct gene expression programs 4.29
Overexpression of UGT2B17 in MEC1 and JVM2 leukemia cell lines 4.28
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived AREG 4.25
Comparison of expression profiles of APP-depleted prostate cancer cells (LNCaP) 4.23
ATF4 inhibition by p62 represses stromal metabolic reprogramming and tumorigenesis II 4.22
Effect of PBK knockdown on C4-2 cell transcriptome 4.18
Downregulation of DDX5/DDX17 and REST 4.15
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.14
CXCR4 regulates extra-medullary myeloma through epithelial-mesenchymal transition-like transcriptional activation 4.14
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 4.1
Zika infected neural stem cells 4.06
Transcriptome analysis of Zika infected neural stem cells 4.06
Analysis of Th17 gene signature in the presence of CD28 costimulation in human CD4 naïve T cells 4.01
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 3.98
Genome-wide probing of RNA structure reveals active unfolding of mRNA structures in vivo 3.95
RNA-Seq in two Ewing sarcoma cell lines: A673 and SKNMC 3.94
PolyA+ RNA-seq in ALL-SIL upon TLX1 knockdown 3.91
RNA-seq analysis of control and CDK12-depleted ovarian cancer cells 3.88
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes 3.84
DNA breaks and chromatin structural changes enhance the transcription of Autoimmune Regulator target genes [RNA-Seq] 3.84
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 3.84
Gene expression comparison of resting human peripheral-blood NK cells and activated counterparts 3.82
3’ Uridylation Expands miRNA Target Repertoire 3.8
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression 3.78
EHMT1 and EHMT2 inhibition induce fetal hemoglobin expression [RNA-seq] 3.78
DGCR8 acts as a novel adaptor for the exosome complex to degrade double-stranded structured RNAs 3.78
CRISPR activation of long non-coding RNAs transiently expressed during cortical neuron differentiation associated with Field, et al, Stem Cell Reports 2018 3.76
Generation of KRAS signatures using immortalized isogenic lung cells. 3.74
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 3.71
Differential expression of pancreatic cancer PANC1 cells treated with pilocarpine 3.7
The role of FAM46C in myeloma cells [sequencing] 3.64
The role of FAM46C in myeloma cells 3.64
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition 3.6
The ALK downregulated target gene HBP1 and repressor of MYCN activity as synergistic target for combined PI3K/HDAC inhibition [RNA-Seq] 3.6
Alternative splicing of differentiated myeloid cell transcripts after infection by Anaplasma phagocytophilum impacts a selective group of cellular programs 3.56
RBM25 is a global splicing factor promoting inclusion of alternatively spliced exons 3.56
DHX36 resolves G-rich structures in mRNA untranslated region to allow their translation [cPDS-RNA-seq] 3.48
Global Mapping of Human RNA-RNA Interactions 3.48
An improved method for circular RNA purification that efficiently removes linear RNAs containing G-quadruplexes or structured 3’ ends 3.47
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 3.46
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 3.46
RNA-seq data from human lymphoma cell lines 3.46
ChIP-seq and RNA-seq from human lymphoma cell lines 3.46
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L [RNA-Seq KO] 3.46
RNA-Seq analysis RPE1 cells following exposure to Nutlin-3 to identify target genes of p53 [tpo12] 3.44
Gene expression profiles in NORAD knockout and PUMILIO overexpressing cells 3.43
RNA sequence of mRNA in HUVEC cells after depleting EGFL6 3.4
RNAseq of T-ALL upon long non coding rna purturbation 3.38
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer 3.37
Grainyhead-like 2 is essential for androgen receptor expression and activity in prostate cancer (RNA-seq) 3.37
BASP1 modifies the Tamoxifen response 3.33
Biochemical fractionation of HEK293 nuclei and RNA-seq of chromatin-associated and soluble-nuclear RNA 3.31
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 3.3
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 3.29
RNA sequencing of primary human platelets and in vitro cell lines 3.29
SUV420H2 knockdown in PANC-1 3.29
Multiplexed engineering and analysis of endogenous enhancer activity in single cells: Mosaic-Seq of beta-globin locus (separate infection) 3.27
Pan-cancer transcriptomic analysis associates long non-coding RNAs with key mutational driver events 3.27
ChIP-seq of ER and RUNX2 in MCF7 breast cancer cell lines 3.27
Epigenetic siRNA and chemical screens identify SETD8 inhibition as a new therapeutic strategy of p53 reactivation in high-risk Neuroblastoma. 3.26
LIN28A Over-expression RNAseq 3.25
Genome-wide RNA-seq from GALNT14-depleted and GALNT14 overexpressing MDA-MB-231 LM2 and Par cells 3.24
The pause-initiation limit restricts transcription activation in human cells 3.24
Gene expression profiles of primary human NK cells before and after expansion on CSTX002 feeder cells, with and without IL-21 stimulation 3.24
The evolution of N6-methyladenosine in primates 3.23
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 3.19
Circular RNAs are down-regulated in KRAS mutant colon cancer cells and can be transferred to exosomes 3.19
Integrin signaling regulates YAP/TAZ to control skin homeostasis 3.18
Transcriptomes analysis for the regulation of Z36 induced autophagy in HeLa cell death 3.18
Identification of HOXB13 target genes responsive to BET inhibitors 3.17
TGF-β promotes genomic instability after loss of RUNX3 3.17
Effect of drugs on transcriptomic profiles 3.16
Huntingtin aggregation impairs autophagy leading to Argonaute-2 accumulation and global microRNA dysregulation 3.16
Cellular acidosis triggers MondoA transcriptional activity by driving mitochondrial ATP production 3.14
RNA-Sequencing experiment for effects of PKF115-584 treatment on four T-ALL cell lines (RPMI8402, HPB-ALL, Jurkat, CCRF-CEM). 3.13
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 3.12
The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth 3.11
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 3.09
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 3.09
Wnt addiction of genetically defined cancers reversed by PORCN inhibition 3.08
Characterisation of HIF-dependent alternative isoforms in pancreatic cancer 3.06
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 3.06
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 3.06
FBXW7 modulates stress response by post-translational modification of HSF1 3.06
Transriptional profiling upon heat shock and recovery in cells deficient for FBXW7 and their wild type counterpart. 3.06
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.05
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 3.05
Expression analysis of genes modulated after knock-down of lncRNA CHROME. 3.05
CD73 knockdown effect in pancreatic cancer cell lines 3.04
A novel lncRNA lncRNA-AK096729 promotes colorectal carcinogenesis and glucose metabolism by stabilizing and specifying the transcription modification pattern of c-Myc 3.03
Transcriptome Analysis of CircMRPS35 mediated mRNA expression profiles 2.98
Disease modelling of core pre-mRNA splicing factor haploinsufficiency 2.98
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription 2.97
The histone H3.3K27M mutation in pediatric glioma reprograms H3K27 methylation and gene expression 2.96
Distinct gene expression profile of Huh7 cell lines stably overexpressing CRABP1 or 2 2.96
Biosynthesis of histone messenger RNA employs a specific 3' end endonuclease 2.96
transcriptomic profiling of HEK293 cells upon individual knockdown of the splicing factors RBM17, U2SURP or CHERP 2.95
Cancerous inhibitor of PP2A (CIP2A) Constrains Th17 Differentiation by Modulating STAT3 Signaling 2.95
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 2.94
Gene expression changes due to PARP knockdown in human cells 2.92
CHD1 loss sensitizes prostate cancer to DNA damaging therapy by promoting error-prone double-strand break repair 2.92
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.92
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 2.92
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma [RNA-Seq] 2.88
Direct interaction of MYCN and p53 regulate transcriptional responses in neuroblastoma 2.88
MOF acetyl transferase regulates transcription and respiration in mitochondria 2.86
RNA seq comparison between scrambled and shGRP78 cells 2.86
Evidence for rRNA 2'-O-methylation plasticity: control of intrinsic translational capabilities of human ribosomes 2.86
Gene expression profile of LMSU gastric cancer cell p53 KO and KD 2.85
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 2.85
Characterization of human CDK12 and CDK13 in the regulation of RNA processing 2.85
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 2.83
LINE-1 elements are derepressed in senescent cells and elicit a chronic Type-I Interferon response 2.83
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 2.82
Transcriptomic Reprogramming of Prostate Cancer Cells Driven by Stroma-Derived SPINK1 2.82
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 2.81
Cap-specific terminal N6-methylation of RNA by an RNA polymerase II-associated methyltransferase. 2.79
An alternative CTCF isoform antagonizes canonical CTCF occupancy and changes chromatin architecture to promote apoptosis 2.79
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 2.73
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 2.68
Contribution of SRF and Nkx2-5 to androgen-dependent gene expression in prostate cancer 2.68
Targeting MYC dependency in ovarian cancer through inhibition of CDK7 and CDK12/13 2.67
Patient-iPSC-derived kidney organoids show functional validation of a ciliopathic renal phenotype 2.67
ERK potentiates transactivation and oncogenic function of ERG by phosphorylation induced dissociation of PRC2 complex 2.67
Widespread N6-methyladenosine-dependent RNA Structural Switches Regulate RNA-Protein Interactions 2.66
Fisetin induces autophagy in pancreatic cancer cells via endoplasmic reticulum stress- and mitochondrial stress-dependent pathways 2.66
RNA-seq of resting and activated CD4+ T cells +-JQ1 2.66
Global host gene expression changes in KSHV+ PEL cells upon KSHV reactivation 2.64
Major hnRNP proteins act as general TDP-43 functional modifiers both in Drosophila and human neuronal cells. 2.63
MYT1 attenuates neuroblastoma cell differentiation by inhibiting retinoic acid signaling pathway 2.63
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 2.63
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 2.63
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 2.63
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling [RNA-seq] 2.62
The Adenovirus E1A C Terminus Suppresses a Delayed Antiviral Response and Modulates RAS Signaling 2.62
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 2.62
The Polycomb protein BMI1 induces an invasive gene expression signature in melanoma that promotes metastasis and chemoresistance. 2.61
RNA Sequencing of default, melanocyte biased and enteric human neural crest populations (NC) and neuroectoderm (CNS) 2.6
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 2.57
Global analysis of alternative splicing regulated by RBM10 2.55
Differential Protein Occupancy Profiling of the mRNA Transcriptome 2.55
Transcriptome landscape of HeLa response upon triamcinolone acetonide 2.49
Effect of disulfiram treatment on pediatric high grade glioma 2.46
Paxillin regulates genomic networks in prostate cancer [C4-2] 2.43
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 2.42
Epigenetic silencing of the tumor suppressor RASSF4 favors multiple myeloma progression 2.42
RNA-sequencing and MeDIP-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.41
RNA-sequencing of shSRC-1 and shNT tamoxifen treated LY2 cells 2.41
PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition 2.39
Gene expression in PANC-1 and AsPC-1 human pancreatic carcinoma cells under hypoxia, nutrient starvation and low pH culture condition. 2.39
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.37
Interactome (iCLIP) and Translatome ( Polysome profiling) of Musashi 2 (MSI2) targets in K562 2.37
Genome-wide profile of cJun and p27 and gene expression profile in breast cancer cells 2.36
Gene expression profile in breast cancer cells 2.36
Identification of global XBP1s target gene expression in human prostate cancer cells 2.36
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 2.35
Integrative classification of human coding and non-coding genes based on RNA metabolism profiles 2.34
High-throughput RNAi cell viability screen to identify selective targets for EWS-FLI1 positive Ewing sarcoma 2.31
K562 polyA RNA-Seq 2.31
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 2.3
Tracing transcriptome profiles of human oocyte cultured by growth hormone or not in vitro by single cell RNA-seq 2.29
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma shRNA Clone TRCN0000005418 targeting RIOK3 with puromycin selection RNAseq 2.28
PTBP1 excludes UPF1 to protect long 3'UTRs from nonsense-mediated mRNA decay 2.27
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 2.26
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 2.25
Canonical poly(A) polymerase activity promotes the decay of a wide variety of mammalian nuclear RNAs 2.25
Global transcriptome analysis of HAP1 cells 2.24
Targeted reactivation of FMR1 transcription in FXS embryonic stem cells 2.24
Microenvironmental-derived Regulation of HIF-Signaling Drives Transcriptional Heterogeneity in Glioblastoma Multiforme 2.23
Allosteric Antagonist Modulation of TRPV2 by Piperlongumine Impairs Glioblastoma Progression 2.2
HEK293 TFAM Knockout Expression Study 2.2
N6-methyladenosine mRNA marking promotes selective translation of regulons required for human erythropoiesis[Ribosome Profiling] 2.2
ILF2 Regulates RNA Splicing of DNA Damage Response Genes to Confer Poor Prognosis in 1q21-Amplified Multiple Myeloma 2.19
Cajal bodies are linked to genome conformation 2.19
Cajal bodies are linked to genome conformation [RNA-Seq] 2.19
Total RNA-seq in ALL-SIL upon TLX1 knockdown 2.19
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 2.16
RNAseq Study in CC-671 Treated Cal-51 Cells 2.14
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 2.13
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships 2.13
RNA:DNA hybrids in the human genome have distinctive nucleotide characteristics, chromatin composition, and transcriptional relationships (RNA-seq) 2.13
Effect of digoxin treatment on the gene and alternative splice expression in human pluripotent stem cells- derived mesenchymal stem cells 2.13
mRNA expression profile of Lymphocytes 2.12
Ewing sarcoma resistance to SP-2509 is not mediated through KDM1A/LSD1 mutation II 2.11
Poly(A)-specific ribonuclease (PARN) mediates 3' end maturation of the telomerase RNA component 2.08
Whole blood stabilization for the microfluidic isolation and molecular characterization of circulating tumor cells 2.06
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 2.06
HDAC and NFκB antagonists synergistically inhibit growth and metastatic dissemination of MYC-driven medulloblastoma 2.04
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 2.02
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 2.02
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 2.02
MYC interacts with the G9a histone methyltransferase to drive transcriptional repression and tumorigenesis 2.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability (22RV1 RNA-seq) 2.02
Selective Inhibition of the Second Bromodomain of BET Family Maintains Anti-Tumor Efficacy and Improves Tolerability 2.02
RNA-sequencing of human vascular endothelial cells after si-RNA mediated gene silencing of interleukin-6 (IL6) 2.01
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 2.01
The contribution of Alu exons to the human proteome 2.01
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 2.01
Transcriptional study of ARN8 cells treated with novel DHODH inhibitors 2.0
Next Generation Sequencing (RNA-Sequencing) for the analysis of RUNX3 targets in H460, H460-ERT2-RUNX3 WT and H460-ERT2-RUNX3 MT(K94/171R mutation) 1.99
CENPA-Bound Genes and Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cells 1.97
Transcriptional Profiling of CENPA-Depleted Prostate Cancer Cell Lines 1.97
Mitochondrial unfolded protein response controls matrix pre-RNA processing and translation 1.96
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer 1.96
Systematic Functional Perturbations Uncover a Prognostic Genetic Network Driving Human Breast Cancer [RNA-Seq] 1.96
Silencing p300 in MCF7 cells to study expression and alternative splicing 1.95
The DPYSL2 gene connects mTOR and schizophrenia 1.95
Real-time observation of light-controlled transcription in living cells 1.93
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 1.91
Developmental stage specific chromosome architecture in human erythroid cells (RNA-seq) 1.88
Developmental stage specific chromosome architecture in human erythroid cells 1.88
Transcription control by the ENL YEATS domain in acute leukemia 1.87
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 1.87
Prolyl hydroxylation regulates protein degradation, synthesis, and splicing in human induced pluripotent stem cell-derived cardiomyocytes 1.86
Combinatorial Reprogramming of Estrogen Signaling by the Nuclear Receptor Family 3C 1.84
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation 1.83
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 1.83
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells 1.81
ETV4 is necessary for estrogen signaling and growth in endometrial cancer cells [RNA-seq] 1.81
High capacity of the endoplasmic reticulum to prevent secretion and aggregation of amyloidgenic proteins 1.81
Lysine benzoylation is a novel histone mark [RNA-seq] 1.79
Lysine benzoylation is a novel histone mark 1.79
Luminal subtype-specific circRNAs in breast cancer cells by a novel tool for external data analysis. 1.77
Identification of long noncoding RNAs regulated by p53 1.77
Rnase L reprograms translation by widespread mRNA turnover escaped by antiviral mRNAs 1.76
The oncogenic BRD4-NUT chromatin regulator drives aberrant transcription within large topological domains 1.76
Recovery and analysis of nascent RNA 1.76
CRISPR adenine and cytosine base editors with reduced RNA off-target activities 1.74
CRISPR adenine and cytosine base editors with reduced RNA off-target activities [CBE] 1.74
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 1.73
Polysome profiling RNAseq of cells transfected with an oligonucleotide targeting the ES6S region of the 40S subunit 1.73
A systematic analysis of nuclear heat-shock protein 90 identifies a metazoan-specific regulatory module 1.73
Small molecule inhibition of ERK dimerization prevents tumorigenesis by Ras-ERK pathway oncogenes 1.72
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 1.72
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 1.72
12hr 5-FU treatment vs. DMSO in SJSA cells (from 'A kinase independent role for CDK19 in p53 response') 1.68
Heterozygous and homozygous knock-in of PIK3CA-H1047R into human iPSCs 1.64
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer 1.63
Mutated H3 Histones Drive Human Pre-Leukemic Hematopoietic Stem Cell Expansion And Promote Leukemic Aggressiveness 1.63
CREB5 promotes resistance to androgen-receptor antagonists and androgen deprivation in prostate cancer 1.61
Transcriptomics analysis of gene expression in multiple human and mouse cells and tissues 1.6
FUS KO mRNA sequencing and anti-FUS RNA immunoprecipitation sequencing 1.58
m6A-RNA mapping, SND1-RNA binding profile mapping and SND1-depletion in KSHV-infected B-lymphocytes 1.54
ZEB1 insufficiency causes corneal endothelial cell state transition and altered cellular processing 1.51
O-glcnAc reprograms cellular energetics 1.5
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.49
Hypoxic transcriptome of SQ20B human head and neck cancer cells 1.47
eVIP2: Expression-based variant impact phenotyping to predict the function of gene variants 1.41
Targeting HuH7 cells with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 1.39
Pseudouridylation of tRNA-derived fragments steers translation control in stem cells [Polysome-Seq] 1.38
RNA-seq of HEK293T cells overexpressing TET1-FL or TET1-ALT 1.37
Epigenetic reprogramming of melanoma cells by vitamin C treatment 1.35
RNA-seq analysis of control and Myc-induced U2OS cells 1.35
Identification of altered developmental pathways in human juvenile HD iPSC with 71Q and 109Q using transcriptome profiling 1.33
Pre-mRNA Splicing is Facilitated by an Optimal RNA Polymerase II Elongation Rate 1.31
RNA-Guided Human Gene Activation by Cas9/CRISPR-Based Engineered Transcription Factors 1.31
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer [RNA-seq] 1.3
Increased Serine and One Carbon Pathway Metabolism by PKCl/i Deficiency Promotes Neuroendocrine Prostate Cancer 1.3
Integrin αvβ3 acting as membrane receptor for thyroid hormones mediates angiogenesis in malignant T cells 1.29
Identification of long noncoding RNAs in T-ALL cell lines 1.28
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.25
RNA-seq analysis of YFV-17D specific and total naive CD8 T cells in humans 1.25
Efficient and precise editing of endogenous transcripts with SNAP-tagged ADARs 1.24
Induction of human regulatory innate lymphoid cells from group 2 innate lymphoid cells by retinoic acid 1.24
A20 regulates canonical wnt-signaling through an interaction with RIPK4 1.22
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.22
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.2
RNA transcriptome analysis of IRF1 and IRF3 knockout in immortalized primary hepatocytes infected with hepatitis A virus 1.19
Campylobacter concisus pathotypes induce distinct global responses in intestinal epithelial cells [UNSWCD] 1.17
HeLa transcriptome induction by IFN gamma and indoleamine 2,3-dioxygenase (IDO) 1.16
Transcriptome analysis of V336Y mutant mitochondrial ribosomal protein in human HEK293 cell line 1.16
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo [RNA-Seq] 1.13
CRISPR Display: A modular method for locus-specific targeting of long noncoding RNAs and synthetic RNA devices in vivo 1.13
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.13
Gastrointestinal Stromal Tumor Enhancers Support a Transcription Factor Network Predictive of Clinical Outcome 1.13
pSILAC mass spectrometry reveals ZFP91 as novel IMiD dependent substrate of the CRL4CRBN ligase 1.11
Canonical and non-canonical regulatory roles of androgen receptor variant 7 in prostate cancer 1.07
RNA sequencing of isogenic BRCA2 haploinsufficient vs. wild-type T-ALL cells 1.06
Bromodomain protein BRD4 is a transcriptional repressor of autophagy and lysosomal function 1.06
RG/RGG boxes are common binding motifs in RNA-G-quadruplex-interacting proteins 1.04
To identify transcripts that are differentially expressed in the MYCN amplified vs MYCN non-amplified cell lines using Next Generation Sequencing 1.04
THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors 0.97
6mer seed toxicity in tumour suppressive microRNAs 0.97
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.94
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.94
SETBP1-WT and SETBP1-G870S transcriptional profiles [RNA-Seq] 0.94
SETBP1-WT and SETBP1-G870S epigenetic landscapes 0.94
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 0.91
Aberrant downstream mechanisms following loss of KMT2C and KMT2D in Pancreatic Ductal Adenocarcinoma 0.9
Early transcriptome profiling of microRNA-mediated neuronal reprogramming [RNA-seq timecourse] 0.89
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 0.88
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer [RNA-seq] 0.86
Estrogen-independent molecular actions of mutant estrogen receptor alpha in endometrial cancer 0.86
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 0.85
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 0.85
Knockout human reveal an essential role for Paternally Expressed 10 (PEG10) in JEG3 cell line development 0.84
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 0.84
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 0.84
Transposon-based construction of strand-specific RNA-seq libraries 0.84
RelA mutants 'reconstituted' and cell cycle synchronized HCT116 Colorectal Cancer Cells 0.84
Gene expression profiling by RNA-seq of SW480 TGM2 knockdown cells 0.83
Gene expression changes after LOC550643 silencing 0.83
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 1] 0.83
Compare of gene expression between p16INK4A positive and negative regions of colon cancer from five patients 0.82
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.81
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.81
SF3B1 Degron knockdown RNA-seq 0.79
Transcriptome Analysis Reveals Distinct Responses to Physiologic versus Toxic Manganese Exposure in Human Neuroblastoma Cells 0.76
Global transcriptome analysis of WT versus HEB-/- hESCs 0.76
Osmostress induced changes of chromatin architecture and transcription in mammalian cells 0.75
Osmostress induced changes of chromatin architecture and transcription in mammalian cells [RNA-Seq, HiC] 0.75
Controlling for gene expression changes in transcription factor protein networks. 0.75
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.73
Transcriptome-wide modulation of splicing by the exon junction complex 0.72
Human stem cell based models of neuronal migration provide insight into neurological disease pathogenesis and potential treatment 0.72
CBFβ-MYH11 fusion blocks hematopoietic differentiation via repression of a GATA2 gene program 0.72
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers [RNA-Seq] 0.71
Multiplex Enhancer Interference Reveals Collaborative Control of Gene Regulation by Estrogen Receptor Alpha Bound Enhancers 0.71
Xrn2 accelerates termination by RNA polymerase II, which is underpinned by CPSF73 activity 0.7
Role of FGFR1 in neuronal devlopment 0.68
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 0.68
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 0.67
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 0.67
Functional significance of the HIV-1 Tat signature amino acid residues 0.66
Effect of PDZ domain binding Kinase inhibition using TOPK-32 (called PBKi) on C4-2 cell transcriptome 0.65
p53 activity results in DNA replication fork processivity 0.64
single cell RNA-seq from Purkinje cell (ENCSR888LYA) 0.63
Combined MEKi (GDC-0973) and WNT (G007-LK) treatment in APC and KRAS mutant HCT-15 cell line 0.59
Modeling genome-wide transcriptional cis-regulation in n LNCaP-abl cell line after siRNA knock down of a series of gene factors [RNA-seq] 0.58
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HEK293 cells treated with or without TNF-alpha 0.57
Regulation of stem cell property and drug resistance of cancer cells by targeting transcriptional machinery via inhibition of neddylation 0.56
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 0.54
Transcriptomics analysis of gene expression in normal and YTHDC1, SRSF1, SRSF3, SRSF7, SRSF9 or SRSF10 deficient human HeLa cells 0.54
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery 0.54
Arginine methylation controls cell proliferation by integrating E2F activity with the splicing machinery (RNA-seq data set) 0.54
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma (RNA-Seq) 0.53
The role of miR-17-92 in the miRegulatory landscape of Ewing Sarcoma 0.53
Oncolytic reactivation of KSHV as a therapeutic approach for primary effusion lymphoma: RNA-sequencing of PEL cell lines during KSHV reactivation 0.53
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 0.51
A novel compound that blocks HIV-1 replication inhibits the splicing regulatory function of SRSF10 0.45
Genetic-to-epigenetic Therapy for Pancreatic Cancer 0.45
Effect on small molecule RBPJ inhibitor (RIN1) on gene expression in Jurkat cells compared to gamma secretase inhibition and siRNA knockdown of RBPJ 0.41
The Short Isoform of BRD4 Promotes HIV-1 Latency by Engaging Repressive SWI/SNF Chromatin Remodeling Complexes 0.39
Identification of trans regulators of ADAR and A-to-I RNA editing using RNA-seq 0.39
Unbiased identification of trans regulators of ADAR and A-to-I RNA editing 0.39
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.37
Transcription factors and stress response gene alterations in human keratinocytes following Solar Simulated Ultra Violet Radiation 0.37
Analysis of gene expression, motif and pattern of m6A modified region and m6A enrichment level in Ocular melanoma and Melanocyte cell lines. Gene expressin analysis of METTL3 knock down in PIG1, ALKBH5 knock down and HINT2 over expression in OCM1. 0.36
RNA-Seq of PRMT1 overexpression ECA109 cells 0.36
RNAseq of CCRF-CEM, a T-cell acute lymphoblastic leukemia cell line, after knockdown with 2 control hairpins and 6 hairpins targeting the PRC2 complex. 0.35
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.34
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.33
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 0.33
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 0.33
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.32
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 0.31
Modulation of nonsense-mediated decay by rapamycin 0.3
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. 0.27
The human cellular nucleic acid binding protien binds G-rich elements close to translation initiation sires and promotes translation. [RNA-Seq] 0.27
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.25
The immediate impact of exoribonucleolysis on nuclear RNA processing, turnover and transcriptional control revealed by rapid depletion of DIS3, EXOSC10 or XRN2 from human cells 0.22
LSD1 mediates MYCN control of epithelial-mesenchymal transition through silencing of metastatic suppressor NDRG1 gene 0.19
Role of COP1 on MAP kinase transcriptional output in gastrointestinal stromal tumor 0.19
The effect of doxycycline-induced expression of host-cell-factor 2 (HCF-2) proteins on the global gene expression in HEK-293 cells 0.18
A Non-Canonical Nuclear Activity Triggered by Small RNAs and Argonaute Proteins in Human Cells 0.17
Transcriptome analysis of the HepG2 cells expressing hepatic transcription factors 0.17
Genome wide characterization of a STAT1-independent antiviral and immunoregulatory transcriptional program induced by IFNβ and TNFα reveals non-canonical STAT2 and IRF9 pathways 0.17
Transcriptome profiling of A2M treated A549 Cell Line Samples 0.12
Mutant KRAS/BRAF Reprograms the Enhancer Landscape via GATA1 to Drive Chemoresistance 0.11
The Small Molecule ISRIB Reverses the Effects of eIF2α Phosphorylation on Translation and Stress Granule Assembly 0.11
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle [RNA-seq] 0.1
O-GlcNAc transferase fine-tunes MYC-dependent transcription to promote cell cycle 0.1
An intramolecular salt bridge linking TDP43’s RNA recognition motifs dictates RNA binding, protein stability and TDP43-dependent neurodegeneration 0.08
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.08
Oncogenic roles of ARID5B in T-ALL 0.08
Human Adult Sorted Live Cell Erythroblasts transduced with Sigma non-targeting shRNA negative control (SHC002V) with puromycin selection RNAseq 0.06
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 0.03
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 0.03
Human Cord Blood Sorted Live Cell Erythroblasts RNA-Seq 0.03
CNOT1 and Transcriptomic Landscape of a HeLa Cell Line 0.01
Human SETMAR is a DNA sequence-specific histone-methylase with a broad effect on the transcriptome 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation